Heart failure & cardiomyopathies

Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

JAMA CardiolPublished Cross-sectional study

Authors' conclusion

In this cross-sectional study, ATTR-CA was an important cause of HF in older Black individuals with HF, particularly in men older than 75 years. Approximately half of V142I carriers with HF had ATTR-CA, while 55.8% of all ATTR-CA cases had normal TTR genotype.

Study context

Population
Self-identified Black or Caribbean Hispanic individuals older than 60 years with heart failure (HF), several major US cities
Participants
646 participants
Outcome
Prevalence of ATTR-CA (radionuclide imaging) and proportions attributable to ATTRwt-CA or ATTRv-CA
Methodological detailsprospective, multicenter, Enrolled May 2019 to June 2024
  • Prospective
  • Multicenter
  • Enrolled May 2019 to June 2024

Main finding

As reported in the abstract

Overall prevalence of ATTR-CA

Overall prevalence of ATTR-CA

6.66%

95% CI 4.73%–8.58%

ATTRwt-CA among ATTR-CA cases

24

55.8%

ATTRv-CA owing to V142I among ATTR-CA cases

19

44.2%

Observational data: associations, not effects.

Further findings

Men vs Women

OutcomeMenWomenP value
Prevalence of ATTR-CA by sex (subgroup)8.15% (95% CI 5.15%–11.15%)5.20% (95% CI 2.79%–7.61%)P = 0.13

Black vs Hispanic

OutcomeBlackHispanicP value
Prevalence of ATTR-CA by ethnicity (subgroup)7.82% (95% CI 5.57%–10.06%)2.15% (95% CI 0.07%–4.24%)P = 0.004

Aged ≤75 years vs Older than 75 years

OutcomeAged ≤75 yearsOlder than 75 yearsP value
Prevalence of ATTR-CA in Black participants by age (subgroup)3.42% (95% CI 1.43%–5.40%)14.04% (95% CI 9.53%–18.54%)P < 0.001

V142I allele

Overall prevalence of V142I allele
5.6%
V142I carriers with ATTRv-CA
19 (52.8%)

Prevalence of ATTR-CA in Black men older than 75 years (subgroup)

Prevalence
17.17% (95% CI 9.74%-24.60%)

Original publication

Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. Published 1 October 2025. doi:10.1001/jamacardio.2025.2948

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.